Insider Transactions

Date Name Title Type Shares Traded Price Range
May 31, 2019 Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 6,650 --
May 31, 2019 Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 6,650 $10.68
May 31, 2019 Director Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 3,780 $18.79
May 23, 2019 SVP/GM, Vascular Access Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 858 $19.15
Apr 04, 2019 Director, President and CEO Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 4,232 $22.95
Feb 12, 2019 SVP and GM of Oncology Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 490 $22.90
Jan 31, 2019 SVP/GM, Global Vascular Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 981 $21.10
Jan 23, 2019 SVP and GM of Oncology Initial Statement of Beneficial Ownership of Securities -- --
Jan 23, 2019 SVP and GM of Oncology Initial Statement of Beneficial Ownership of Securities -- --
Jan 23, 2019 SVP and GM of Oncology Initial Statement of Beneficial Ownership of Securities -- --
 For recent transactions, including derivative transactions, see our Section 16 SEC filings page.